IDH1-mutant Glioma research hub

Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma

This study looks at a new drug, Vorasidenib, with a standard cancer drug, Temozolomide (TMZ), for a type of brain tumour called glioma. It aims to check if this combination is safe and how well it works.